19.07.2019 05:46:46
OMX NORDIC SUP/HEALTH CARE(TR)
3139.67
EUR
3.7360
0.12%
18.07.2019 17:35
 
Chart
Kursdaten
Kurs - Eröffnung -
Diff. absolut - Tages-Hoch -
Diff. % - Tages-Tief -
Volumen - Umsatz -
Schlusskurs vom 17.07.2019 3135.94 Volatilität in % -
Börse Letzter Handel 18.07.2019 / 17:35
Währung EUR Aktualisierungsstand 19.07.2019 / 05:46
Kursentwicklung (berechnet mit Vortageskurs)
Zeitraum Perf. Hoch Tief
2019 12.13% 3286.5 2787.5
1 Woche -0.80% 3160.9 3099.3
1 Monat -3.59% 3286.5 3099.3
3 Monate 1.50% 3286.5 3021.8
6 Monate 6.95% 3286.5 2850.6
1 Jahr -0.22% 3286.5 2698.2
3 Jahre 13.34% 3286.5 2087.2
21.86
13
0.39
SMI
12.13
18.75
SMI
-10.68
SMI
2017
2018
2019
{"2017":{"performance":21.86,"chartHeight":23.63117091087,"year":2017,"ID_NOTATION":"57305643"},"2018":{"performance":0.39,"chartHeight":8.102284055819,"year":2018,"ID_NOTATION":"57305643"},"2019":{"performance":12.13,"chartHeight":20.666125180776,"year":2019,"ID_NOTATION":"57305643"}}
{"2017":{"performance":13,"chartHeight":21.014834532223,"year":2017,"ID_NOTATION":"1555183","BENCHMARK_NAME":"SMI"},"2018":{"performance":-10.68,"chartHeight":20.025222678745,"year":2018,"ID_NOTATION":"1555183","BENCHMARK_NAME":"SMI"},"2019":{"performance":18.75,"chartHeight":22.858593834058,"year":2019,"ID_NOTATION":"1555183","BENCHMARK_NAME":"SMI"}}
{"2017":{"performance":6.87,"chartHeight":17.804075526155,"year":2017,"ID_NOTATION":"193736","BENCHMARK_NAME":"EStoxx50"},"2018":{"performance":-14.4,"chartHeight":21.529730001053,"year":2018,"ID_NOTATION":"193736","BENCHMARK_NAME":"EStoxx50"},"2019":{"performance":16.04,"chartHeight":22.072709169121,"year":2019,"ID_NOTATION":"193736","BENCHMARK_NAME":"EStoxx50"}}
{"2017":{"performance":24.39,"chartHeight":24.182493481119,"year":2017,"ID_NOTATION":"324977","BENCHMARK_NAME":"DJI"},"2018":{"performance":-5.97,"chartHeight":17.09718285238,"year":2018,"ID_NOTATION":"324977","BENCHMARK_NAME":"DJI"},"2019":{"performance":16.7,"chartHeight":22.27570510037,"year":2019,"ID_NOTATION":"324977","BENCHMARK_NAME":"DJI"}}
{"2017":{"performance":17.9,"chartHeight":22.62504050348,"year":2017,"ID_NOTATION":"60972397","BENCHMARK_NAME":"Nikkei"},"2018":{"performance":-13.82,"chartHeight":21.322765729306,"year":2018,"ID_NOTATION":"60972397","BENCHMARK_NAME":"Nikkei"},"2019":{"performance":5.15,"chartHeight":16.353373983713,"year":2019,"ID_NOTATION":"60972397","BENCHMARK_NAME":"Nikkei"}}
{"2017":{"performance":13.05,"chartHeight":21.034159823262,"year":2017,"ID_NOTATION":"20735","BENCHMARK_NAME":"DAX"},"2018":{"performance":-18.13,"chartHeight":22.689314115408,"year":2018,"ID_NOTATION":"20735","BENCHMARK_NAME":"DAX"},"2019":{"performance":15.81,"chartHeight":22,"year":2019,"ID_NOTATION":"20735","BENCHMARK_NAME":"DAX"}}
Einzelwerte *(Kursentwicklung in % berechnet mit Vortageskurs) Autoupdate 19.07.2019 05:46:46
Titel
Kurs
+/-%
+/-
Volumen Total
Open
Low
High
Volumen Geld
Geld
Brief
Volumen Brief
*+/- in % 1 Wo.
*+/- in % 2019
ADDLIFE AB B - - - - - - - - - - - - -
ALK-Abell B - - - - - - - - - - - - -
ALLIGATOR BIOSC. AB - - - - - - - - - - - - -
ARJO AB B - - - - - - - - - - - - -
ASCELIA PHARMA AB - - - - - - - - - - - - -
ATTENDO AB - - - - - - - - - - - - -
Active Biotech - - - - - - - - - - - - -
Ambea AB - - - - - - - - - - - - -
Ambu - - - - - - - - - - - - -
AstraZeneca - - - - - - - - - - - - -
BACTIGUARD HLDG B - - - - - - - - - - - - -
BIOARCTIC AB B - - - - - - - - - - - - -
BONESUPPORT HOLDING - - - - - - - - - - - - -
Bavarian Nordic - - - - - - - - - - - - -
BioGaia B - - - - - - - - - - - - -
Biohit B - - - - - - - - - - - - -
Bioinvent Internat - - - - - - - - - - - - -
Bioporto A/S - - - - - - - - - - - - -
Biotage - - - - - - - - - - - - -
Boule Diagnostics - - - - - - - - - - - - -
C-RAD B - - - - - - - - - - - - -
CALLIDITAS THERAPEUT - - - - - - - - - - - - -
CAMURUS AB - - - - - - - - - - - - -
CHRISTIAN HANSEN - - - - - - - - - - - - -
COLOPLAST - - - - - - - - - - - - -
Cantargia AB - - - - - - - - - - - - -
Cellavision - - - - - - - - - - - - -
Chemometec - - - - - - - - - - - - -
Dedicare B - - - - - - - - - - - - -
Elekta B - - - - - - - - - - - - -
Elos Medtech ser. B - - - - - - - - - - - - -
Episurf Medical B - - - - - - - - - - - - -
Feelgood Svenska - - - - - - - - - - - - -
GETINGE - - - - - - - - - - - - -
GHP Specialty Care - - - - - - - - - - - - -
GN Store Nord - - - - - - - - - - - - -
Genmab - - - - - - - - - - - - -
H. Lundbeck - - - - - - - - - - - - -
HANDICARE GROUP AB - - - - - - - - - - - - -
HUMANA AB - - - - - - - - - - - - -
Hansa Biopharma - - - - - - - - - - - - -
IMMUNOVIA AB - - - - - - - - - - - - -
INFANT BACT.THER.B S - - - - - - - - - - - - -
Immunicum - - - - - - - - - - - - -
Karo Pharma - - - - - - - - - - - - -
Karolinska Devel B - - - - - - - - - - - - -
MEDICOVER AB - - - - - - - - - - - - -
MedCap - - - - - - - - - - - - -
Medivir B - - - - - - - - - - - - -
Moberg Pharma - - - - - - - - - - - - -
NOVOZYMES - - - - - - - - - - - - -
NeuroVive Pharma - - - - - - - - - - - - -
Neurosearch - - - - - - - - - - - - -
Novo-Nordisk B - - - - - - - - - - - - -
OEssur - - - - - - - - - - - - -
ONCOPEPTIDES AB O.N. - - - - - - - - - - - - -
ONXEO - - - - - - - - - - - - -
ORPHAZYME A/S DK 1 - - - - - - - - - - - - -
Oasmia Pharma - - - - - - - - - - - - -
Orexo - - - - - - - - - - - - -
Oriola 'A' - - - - - - - - - - - - -
Oriola 'B' - - - - - - - - - - - - -
Orion A - - - - - - - - - - - - -
Orion B - - - - - - - - - - - - -
Ortivus A - - - - - - - - - - - - -
Ortivus B - - - - - - - - - - - - -
Pihlajalinna - - - - - - - - - - - - -
Probi Ab - - - - - - - - - - - - -
Q-LINEA AB - - - - - - - - - - - - -
Raysearch Lab B - - - - - - - - - - - - -
Recipharm - - - - - - - - - - - - -
Revenio Group - - - - - - - - - - - - -
SANIONA AB (PUBL) - - - - - - - - - - - - -
SILMAEASEMA OYJ - - - - - - - - - - - - -
Sectra B - - - - - - - - - - - - -
Swedish Orphan Bio - - - - - - - - - - - - -
Terveystalo - - - - - - - - - - - - -
VELOXIS PHARMA - - - - - - - - - - - - -
Vitrolife AB - - - - - - - - - - - - -
WILLIAM DEMANT - - - - - - - - - - - - -
Xvivo Perfusion - - - - - - - - - - - - -
Zealand Pharma - - - - - - - - - - - - -